Stem cells: A promising source for vascular regenerative medicine

Stem Cells and Development

Volumn 23, Issue 24, 2014, Pages 2931-2949

  Rammal, Hassan ^a   Harmouch, Chaza ^a   Lataillade, Jean Jacques ^b   Laurent Maquin, Dominique ^c   Labrude, Pierre ^a   Menu, Patrick ^a   Kerdjoudj, Halima ^c  

^a UNIVERSITÉ DE LORRAINE   (France)

^b Centre de Transfusion Sanguine des Armées Jean Julliard rue du lieutenant Raoul Batany   (France)

^c Universite de Picardie Jules Verne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 1; BONE MORPHOGENETIC PROTEIN 4; CALPONIN; CD133 ANTIGEN; CD31 ANTIGEN; CD9 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; GLUCOSE REGULATED PROTEIN 94; LEUKEMIA INHIBITORY FACTOR; MYOCARDIN; MYOSIN HEAVY CHAIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN; SMOOTHELIN; SOMATOMEDIN B; SOMATOMEDIN C; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; STAT PROTEIN; TELOKIN PROTEIN; TETRACARCINOMA DERIVED GROWTH FACTOR 1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; TRANSGELIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ADULT STEM CELL; AMNION; AMNION FLUID; ANGIOGENESIS; BLASTOCYST; CARTILAGE CELL; CELL DIFFERENTIATION; CELL DIVISION; CELL ISOLATION; CELL RENEWAL; CELL STRUCTURE; CHORION; DAUGHTER CELL; DENSITY GRADIENT CENTRIFUGATION; EMBRYO CELL; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEEDER CELL; FETAL STEM CELL; FETUS MEMBRANE; GENE EXPRESSION; HUMAN; HYDRODYNAMICS; MESENCHYMAL STEM CELL; OSTEOBLAST; OXYGEN TENSION; PHENOTYPE; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; REGENERATIVE MEDICINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SMOOTH MUSCLE FIBER; SPINDLE CELL; STEM CELL; STEM CELL CULTURE; STROMA CELL; TISSUE REGENERATION; TOTIPOTENT STEM CELL; TROPHOBLAST; UMBILICAL CORD BLOOD; UPREGULATION; VASCULAR REGENERATION; VASCULAR REGENERATIVE MEDICINE; VASCULAR TISSUE; WHARTON JELLY; ANIMAL; CLASSIFICATION; CYTOLOGY; METABOLISM; PROCEDURES; STEM CELL TRANSPLANTATION;

ANIMALS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84916883095     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0132     Document Type: Review

References (214)

1. Deedwania P. (2013). Diabetes, cardiovascular disease, and ethnicity. J Am Coll Cardiol 61:1787-1789
2. Li S and JJD Henry. (2011). Nonthrombogenic approaches to cardiovascular bioengineering. Annu Rev Biomed Eng 13:451-475
3. Klopsch C and G Steinhoff. (2012). Tissue-engineered devices in cardiovascular surgery. Eur Surg Res 49:44-52
4. Menu P, JF Stoltz and H Kerdjoudj. (2013). Progress in vascular graft substitute. Clin Hemorheol Microcirc 53: 117-129
5. Caplan AI and JE Dennis. (2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084
6. Kolf CM, E Cho and RS Tuan. (2007). Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204
7. Martin GR. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78:7634-7638
8. Matsui Y, D Toksoz, S Nishikawa, S Nishikawa, D Williams, K Zsebo and BLM Hogan. (1991). Effect of Steel factor and leukaemia inhibitory factor on murine primordial germ cells in culture. Nature 353:750-752
9. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147
10. Reubinoff BE, MF Pera, CY Fong, A Trounson and A Bongso. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18:399-404
11. Talbot NC, WO Sparks, AM Powell, S Kahl and TJ Caperna. (2012). Quantitative and semiquantitative immunoassay of growth factors and cytokines in the conditioned medium of STO and CF-1 mouse feeder cells. In Vitro Cell Dev Biol Anim 48:1-11
12. Smith AG, JK Heath, DD Donaldson, GG Wong, J Moreau, M Stahl and D Rogers. (1988). Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336:688-690
13. Bhattacharya B, T Miura, R Brandenberger, J Mejido, YQ Luo, AX Yang, BH Joshi, I Ginis, RS Thies, et al. (2004). Gene expression in human embryonic stem cell lines: unique molecular signature. Blood 103:2956-2964
14. Iida M, T Heike, M Yoshimoto, S Baba, H Doi and T Nakahata. (2005). Identification of cardiac stem cells with FLK1, CD31, and VE-cadherin expression during embryonic stem cell differentiation. FASEB J 19:371-378
15. Levenberg S, JS Golub, M Amit, J Itskovitz-Eldor and R Langer. (2002). Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 99:4391-4396
16. Wang ZZ, P Au, T Chen, Y Shao, LM Daheron, H Bai, M Arzigian, D Fukumura, RK Jain and DT Scadden. (2007). Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol 25:317-318
17. Cho SW, SH Moon, SH Lee, SW Kang, JM Kim, HS Kim, BS Kim and HM Chung. (2007). Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 116:2409-2419
18. Yamahara K, M Sone, H Itoh, JK Yamashita, T Yurugi-Kobayashi, K Homma, TH Chao, K Miyashita, K Park, et al. (2008). Augmentation of neovascularization in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. PLoS One 3:e1666
19. Levenberg S, LS Ferreira, L Chen-Konak, TP Kraehenbuehl and R Langer. (2010). Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells. Nat Protoc 5:1115-1126
20. Nourse MB, DE Halpin, M Scatena, DJ Mortisen, NL Tulloch, KD Hauch, B Torok-Storb, BD Ratner, L Pabon and CE Murry. (2010). VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol 30:80-89
21. Han Y, N Li, X Tian, J Kang, C Yan and Y Qi. (2010). Endogenous transforming growth factor (TGF) beta1 promotes differentiation of smooth muscle cells from embryonic stem cells: stable plasmid-based siRNA silencing of TGF beta1 gene expression. J Physiol Sci 60: 35-41
22. Li Z, Y Suzuki, M Huang, F Cao, X Xie, AJ Connolly, PC Yang and JC Wu. (2008). Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 26:864-873
23. Shin JM, J Kim, HE Kim, MJ Lee, KI Lee, EG Yoo, YJ Jeon, DW Kim, JI Chae and HM Chung. (2011). Enhancement of differentiation efficiency of hESCs into vascular lineage cells in hypoxia via a paracrine mechanism. Stem Cell Res 7:173-185
24. Han Y, SZ Kuang, A Gomer and DL Ramirez-Bergeron. (2010). Hypoxia influences the vascular expansion and differentiation of embryonic stem cell cultures through the temporal expression of vascular endothelial growth factor receptors in an ARNT-dependent manner. Stem Cells 28:799-809
25. Goldman O, O Feraud, J Boyer-Di Ponio, C Driancourt, D Clay, MC Le Bousse-Kerdiles, A Bennaceur-Griscelli and G Uzan. (2009). A boost of BMP4 accelerates the commitment of human embryonic stem cells to the endothelial lineage. Stem Cells 27:1750-1759
26. James D, HS Nam, M Seandel, D Nolan, T Janovitz, M Tomishima, L Studer, G Lee, D Lyden, et al. (2010). Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nat Biotechnol 28:161-166
27. Piecewicz SM, A Pandey, B Roy, SH Xiang, BR Zetter and S Sengupta. (2012). Insulin-like growth factors promote vasculogenesis in embryonic stem cells. PLoS One 7:e32191
28. Majesky MW. (2007). Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 27:1248-1258
29. Xie CQ, J Zhang, L Villacorta, T Cui, H Huang and YE Chen. (2007). A highly efficient method to differentiate smooth muscle cells from human embryonic stem cells. Arterioscler Thromb Vasc Biol 27:e311-e312
30. Lu SJ, Y Ivanova, Q Feng, C Luo and R Lanza. (2009). Hemangioblasts from human embryonic stem cells generate multilayered blood vessels with functional smooth muscle cells. Regen Med 4:37-47
31. El-Mounayri O, A Mihic, EA Shikatani, M Gagliardi, SK Steinbach, N Dubois, R Dacosta, RK Li, G Keller and M Husain. (2013). Serum-free differentiation of functional human coronary-like vascular smooth muscle cells from embryonic stem cells. Cardiovasc Res 98:125-135
32. Rafii S, CC Kloss, JM Butler, M Ginsberg, E Gars, R Lis, Q Zhan, P Josipovic, BS Ding, et al. (2013). Human ESCderived hemogenic endothelial cells undergo distinct waves of endothelial to hematopoietic transition. Blood 121:770-780
33. Sone M, H Itoh, K Yamahara, JK Yamashita, T Yurugi-Kobayashi, A Nonoguchi, Y Suzuki, TH Chao, N Sawada, et al. (2007). Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol 27:2127-2134
34. Hill KL, P Obrtlikova, DF Alvarez, JA King, SA Keirstead, JR Allred and DS Kaufman. (2010). Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function. Exp Hematol 38:246-257
35. Li Z, MR Barron, J Lough and M Zhao. (2008). Rapid single-step separation of pluripotent mouse embryonic stem cells from mouse feeder fibroblasts. Stem Cells Dev 17:383-387
36. BlancasAA, AJ Shih, NE Lauer andKEMcCloskey. (2011). Endothelial cells from embryonic stem cells in a chemically defined medium. Stem Cells Dev 20:2153-2161
37. Park SW, Y Jun Koh, J Jeon, YH Cho, MJ Jang, Y Kang, MJ Kim, C Choi, Y Sook Cho, et al. (2010). Efficient differentiation of human pluripotent stem cells into functional CD34 + progenitor cells by combined modulation of the MEK/ERK and BMP4 signaling pathways. Blood 116:5762-5772
38. Kane NM, L Howard, B Descamps, M Meloni, J McClure, R Lu, A McCahill, C Breen, RM Mackenzie, et al. (2012). Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells 30:643-654
39. Prado-Lopez S, A Conesa, A Arminán, M Martínez-Losa, C Escobedo-Lucea, C Gandia, S Tarazona, D Melguizo, D Blesa, et al. (2010). Hypoxia promotes efficient differentiation of human embryonic stem cells to functional endothelium. Stem Cells 28:407-418
40. Vo E, D Hanjaya-Putra, Y Zha, S Kusuma and S Gerecht. (2010). Smooth-muscle-like cells derived from human embryonic stem cells support and augment cord-like structures in vitro. Stem Cell Rev 6:237-247
41. Maitra A, DE Arking, N Shivapurkar, M Ikeda, V Stastny, K Kassauei, G Sui, DJ Cutler, Y Liu, et al. (2005). Genomic alterations in cultured human embryonic stem cells. Nat Genet 37:1099-1103
42. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676
43. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872
44. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920
45. Lowry WE, L Richter, R Yachechko, AD Pyle, J Tchieu, R Sridharan, AT Clark and K Plath. (2008). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 105:2883-2888
46. Maherali N, R Sridharan, W Xie, J Utikal, S Eminli, K Arnold, M Stadtfeld, R Yachechko, J Tchieu, et al. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1:55-70
47. Meissner A, M Wernig and R Jaenisch. (2007). Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 25:1177-1181
48. Rufaihah AJ, NF Huang, J Kim, J Herold, KS Volz, TS Park, JC Lee, ET Zambidis, R Reijo-Pera and JP Cooke. (2013). Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity. Am J Transl Res 5:21-35
49. Taura D, M Sone, K Homma, N Oyamada, K Takahashi, N Tamura, S Yamanaka and K Nakao. (2009). Induction and isolation of vascular cells from human induced pluripotent stem cells-brief report. Arterioscler Thromb Vasc Biol 29:1100-1103
50. Azhdari M, M Baghaban-Eslaminejad, H Baharvand and N Aghdami. (2013). Therapeutic potential of humaninduced pluripotent stem cell-derived endothelial cells in a bleomycin-induced scleroderma mouse model. Stem Cell Res 10:288-300
51. Rufaihah AJ, NF Huang, S Jamé, JC Lee, HN Nguyen, B Byers, A De, J Okogbaa, M Rollins, et al. (2011). Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol 31:e72-e79
52. Karamariti E, A Margariti, B Winkler, X Wang, X Hong, D Baban, J Ragoussis, Y Huang, JD Han, et al. (2013). Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through DKK3 signaling are potent for tissue engineering of vascular grafts. Circ Res 112:1433-1443
53. Wang A, Z Tang, X Li, Y Jiang, DA Tsou and S Li. (2012). Derivation of smooth muscle cells with neural crest origin from human induced pluripotent stem cells. Cells Tissues Organs 195:5-14
54. Lee TH, SH Song, KL Kim, JY Yi, GH Shin, JY Kim, J Kim, YM Han, SH Lee, et al. (2010). Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circ Res 106:120-128
55. Margariti A, B Winkler, E Karamariti, A Zampetaki, TN Tsai, D Baban, J Ragoussis, Y Huang, JD Han, et al. (2012). Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc Natl Acad Sci U S A 109:13793-13798
56. Tiscornia G, EL Vivas and JC Izpisúa Belmonte. (2011). Diseases in a dish: modeling human genetic disorders using induced pluripotent cells. Nat Med 17:1570-1576
57. Miki T, T Lehmann, H Cai, DB Stolz and SC Strom. (2005). Stem cell characteristics of amniotic epithelial cells. Stem Cells 23:1549-1559
58. Witkowska-Zimny M and E Wrobel. (2011). Perinatal sources of mesenchymal stem cells: Whartons jelly, amnion and chorion. Cell Mol Biol Lett 16:493-514
59. Erices A, P Conget and JJ Minguell. (2000). Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235-242
60. Matikainen T and J Laine. (2005). Placenta-An alternative source of stem cells. Toxicol Appl Pharmacol 207: 544-549
61. Karahuseyinoglu S, O Cinar, E Kilic, F Kara, GG Akay, DO Demiralp, A Tukun, D Uckan and A Can. (2007). Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 25:319-331
62. Troyer DL and ML Weiss. (2008). Whartons jellyderived cells are a primitive stromal cell population. Stem Cells 26:591-599
63. Spurway J, P Logan and S Pak. (2012). The development, structure and blood flow within the umbilical cord with particular reference to the venous system. AJUM 15:97-102
64. Roura S, JM Pujal and A Bayes-Genis. (2012). Umbilical cord blood for cardiovascular cell therapy: from promise to fact. Ann N Y Acad Sci 1254:66-70
65. Georgiades P, AC Ferguson-Smith and GJ Burton. (2002). Comparative developmental anatomy of the murine and human definitive placentae. Placenta 23:3-19
66. Zhu SF, ZN Zhong, XF Fu, DX Peng, GH Lu, WH Li, HY Xu, HB Hu, JM He, WY Su and YL He. (2013). Comparison of cell proliferation, apoptosis, cellular morphology and ultrastructure between human umbilical cord and placenta-derived mesenchymal stem cells. Neurosci Lett 541:77-82
67. Gucciardo L, R Lories, N Ochsenbein-Kölble, E Done, A Zwijsen and J Deprest. (2009). Fetal mesenchymal stem cells: isolation, properties and potential use in perinatology and regenerative medicine. BJOG Int J Obstet Gynaecol 116:166-172
68. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, DJ Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317
69. Kern S, H Eichler, J Stoeve, H Klüter and K Bieback. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301
70. Yoon DS, YH Kim, HS Jung, S Paik and JW Lee. (2011). Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in lowdensity culture. Cell Prolif 44:428-440
71. Bossolasco P, T Montemurro, L Cova, S Zangrossi, C Calzarossa, S Buiatiotis, D Soligo, S Bosari, V Silani, et al. (2006). Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res 16:329-336
72. Kim HG and OH Choi. (2011). Neovascularization in a mouse model via stem cells derived from human fetal amniotic membranes. Heart Vessels 26:196-205
73. Kim SW, HZ Zhang, CE Kim, HS An, JM Kim and MH Kim. (2012). Amniotic mesenchymal stem cells have robust angiogenic properties and are effective in treating hindlimb ischaemia. Cardiovasc Res 93:525-534
74. Kim SW, HZ Zhang, CE Kim, JM Kim and MH Kim. (2013). Amniotic mesenchymal stem cells with robust chemotactic properties are effective in the treatment of a myocardial infarction model. Int J Cardiol 168:1062-1069
75. Breymann C, D Schmidt and SP Hoerstrup. (2006). Umbilical cord cells as a source of cardiovascular tissue engineering. Stem Cell Rev 2:87-92
76. Meraviglia V, M Vecellio, A Grasselli, M Baccarin, A Farsetti, MC Capogrossi, G Pompilio, DA Coviello, C Gaetano, M Di Segni and A Rossini. (2012). Human chorionic villus mesenchymal stromal cells reveal strong endothelial conversion properties. Differ Res Biol Divers 83:260-270
77. Warrier S, N Haridas and R Bhonde. (2012). Inherent propensity of amnion-derived mesenchymal stem cells towards endothelial lineage: vascularization from an avascular tissue. Placenta 33:850-858
78. Roura S, JR Bagó, C Soler-Botija, JM Pujal, C Gálvez-Montón, C Prat-Vidal, A Llucia-Valldeperas, J Blanco and A Bayes-Genis. (2012). Human umbilical cord bloodderived mesenchymal stem cells promote vascular growth in vivo. PLoS One 7:e49447
79. Chen MY, PC Lie, ZL Li and X Wei. (2009). Endothelial differentiation of Whartons jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp Hematol 37:629-640
80. Benavides OM, JJ Petsche, KJ Moise Jr., A Johnson and JG Jacot. (2012). Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells. Tissue Eng Part A 18:1123-1131
81. Nur Fariha MM, KH Chua, GC Tan, YH Lim and AR Hayati. (2012). Endogenous and induced angiogenic characteristics of human chorion-derived stem cells. Cell Biol Int 36:1145-1153
82. Choi M, HS Lee, P Naidansaren, HK Kim, EO, JH Cha, HY Ahn, PI Yang, JC Shin and YA Joe. (2013). Proangiogenic features of Whartons jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels. Int J Biochem Cell Biol 45:560-570
83. Yamahara K, K Harada, M Ohshima, S Ishikane, S Ohnishi, H Tsuda, K Otani, A Taguchi, T Soma, et al. (2014). Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion-And chorionderived mesenchymal stem cells. PLoS One 9:e88319
84. Wu KH, B Zhou, SH Lu, B Feng, SG Yang, WT Du, DS Gu, ZC Han and YL Liu. (2007). In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J Cell Biochem 100:608-616
85. Finney MR, LR Fanning, ME Joseph, JL Goldberg, NJ Greco, S Bhakta, DG Winter, M Forster, PE Scheid, et al. (2010). Umbilical cord blood-selected CD133( + ) cells exhibit vasculogenic functionality in vitro and in vivo. Cytotherapy 12:67-78
86. Shohara R, A Yamamoto, S Takikawa, A Iwase, H Hibi, F Kikkawa and M Ueda. (2012). Mesenchymal stromal cells of human umbilical cord Whartons jelly accelerate wound healing by paracrine mechanisms. Cytotherapy 14:1171-1181
87. Li P, C Zhou, L Yin, X Meng and L Zhang. (2013). Role of hypoxia in viability and endothelial differentiation potential of UC-MSCs and VEGF interference. Zhong Nan Da Xue Xue Bao Yi Xue Ban 38:329-340
88. Wang SH, SJ Lin, YH Chen, FY Lin, JC Shih, CC Wu, HL Wu and YL Chen. (2009). Late outgrowth endothelial cells derived from wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor. Arterioscler Thromb Vasc Biol 29:816-822
89. Farias VA, JL Linares-Fernández, JL Penalver, JA Payá Colmenero, GO Ferrón, EL Duran, RM Fernández, EG Olivares, F OValle, et al. (2011). Human umbilical cord stromal stem cell express CD10 and exert contractile properties. Placenta 32:86-95
90. Hayward CJ, J Fradette, T Galbraith, M Rémy, R Guignard, R Gauvin, L Germain and FA Auger. (2013). Harvesting the potential of the human umbilical cord: isolation and characterization of four cell types for tissue engineering applications. Cells Tissues Organs 197: 37-54
91. Bajpai VK and ST Andreadis. (2012). Stem cell sources for vascular tissue engineering and regeneration. Tissue Eng Part B Rev 18:405-425
92. Parolini O, F Alviano, GP Bagnara, G Bilic, HJ Bühring, M Evangelista, S Hennerbichler, B Liu, M Magatti, et al. (2008). Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26:300-311
93. De Coppi P, G Bartsch Jr., MM Siddiqui, T Xu, CC Santos, L Perin, G Mostoslavsky, AC Serre, EY Snyder, et al. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100-106
94. Tsai MS, JL Lee, YJ Chang and SM Hwang. (2004). Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel twostage culture protocol. Hum Reprod 19:1450-1456
95. Friedenstein AJ, RK Chailakhjan and KS Lalykina. (1970). The development of fibroblast colonies in mono-layer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403
96. Mikkola HKA and SH Orkin. (2006). The journey of developing hematopoietic stem cells. Development 133: 3733-3744
97. Caplan AI. (1991). Mesenchymal stem cells. J Orthop Res 9:641-650
98. Oswald J, S Boxberger, B Jrgensen, S Feldmann, G Ehninger, M Bornhäuser and C Werner. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22:377-384
99. Pankajakshan D, V Kansal and DK Agrawal. (2012). In vitro differentiation of bone marrow derived porcine mesenchymal stem cells to endothelial cells. J Tissue Eng Regen Med 7:911-920
100. Zhang P, N Moudgill, E Hager, N Tarola, C Dimatteo, S McIlhenny, T Tulenko and PJ DiMuzio. (2011). Endothelial differentiation of adipose-derived stem cells from elderly patients with cardiovascular disease. Stem Cells Dev 20:977-988
101. Lim TY, CK Poh and W Wang. (2009). Poly (lactic-coglycolic acid) as a controlled release delivery device. J Mater Sci Mater Med 20:1669-1675
102. Poh CK, Z Shi, TY Lim, KG Neoh and W Wang. (2010). The effect of VEGF functionalization of titanium on endothelial cells in vitro. Biomaterials 31:1578-1585
103. Shevchenko EK, PI Makarevich, ZI Tsokolaeva, MA Boldyreva, VY Sysoeva, VA Tkachuk and YV Parfyonova. (2013). Transplantation of modified human adipose derived stromal cells expressing VEGF165 results in more efficient angiogenic response in ischemic skeletal muscle. J Transl Med 11:138
104. Wosnitza M, K Hemmrich, A Groger, S Gräber and N Pallua. (2007). Plasticity of human adipose stem cells to perform adipogenic and endothelial differentiation. Differ Res Biol Divers 75:12-23
105. Colazzo F, AH Chester, PM Taylor and MH Yacoub. (2010). Induction of mesenchymal to endothelial transformation of adipose-derived stem cells. J Heart Valve Dis 19:736-744
106. Bai K, Y Huang, X Jia, Y Fan and W Wang. (2010). Endothelium oriented differentiation of bone marrow mesenchymal stem cells under chemical and mechanical stimulations. J Biomech 43:1176-1181
107. Wang N, R Zhang, SJ Wang, CL Zhang, LB Mao, CY Zhuang, YY Tang, XG Luo, H Zhou and TC Zhang. (2013). Vascular endothelial growth factor stimulates endothelial differentiation from mesenchymal stem cells via Rho/myocardin-related transcription factor-A signaling pathway. Int J Biochem Cell Biol 45:1447-1456
108. Fischer LJ, S McIlhenny, T Tulenko, N Golesorkhi, P Zhang, R Larson, J Lombardi, I Shapiro and PJ DiMuzio. (2009). Endothelial differentiation of adipose-derived stem cells: effects of endothelial cell growth supplement and shear force. J Surg Res 152:157-166
109. Zhao L and BM Hantash. (2011). TGF-b1 regulates differentiation of bone marrow mesenchymal stem cells. Vitam Horm 87:127-141
110. Gong Z and LE Niklason. (2008). Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 22:1635-1648
111. Narita Y, A Yamawaki, H Kagami, M Ueda and Y Ueda. (2008). Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrowderived mesenchymal stem cells into smooth muscle cell lineage. Cell Tissue Res 333:449-459
112. Adamo L and G García-Cardena. (2011). Directed stem cell differentiation by fluid mechanical forces. Antioxid Redox Signal 15:1463-1473
113. Wang JHC and BP Thampatty. (2008). Mechanobiology of adult and stem cells. Int Rev Cell Mol Biol 271:301-346
114. Gong Z and LE Niklason. (2011). Use of human mesenchymal stem cells as alternative source of smooth muscle cells in vessel engineering. Methods Mol Biol 698:279-294
115. Maul TM, DW Chew, A Nieponice and DA Vorp. (2011). Mechanical stimuli differentially control stem cell behavior: morphology, proliferation, and differentiation. Biomech Model Mechanobiol 10:939-953
116. Kim DH, SJ Heo, SH Kim, JW Shin, SH Park and JW Shin. (2011). Shear stress magnitude is critical in regulating the differentiation of mesenchymal stem cells even with endothelial growth medium. Biotechnol Lett 33: 2351-2359
117. OCearbhaill ED, MA Punchard, M Murphy, FP Barry, PE McHugh and V Barron. (2008). Response of mesenchymal stem cells to the biomechanical environment of the endothelium on a flexible tubular silicone substrate. Biomaterials 29:1610-1619
118. Bassaneze V, VG Barauna, C Lavini-Ramos, J Kalil, IT Schettert, AA Miyakawa and JE Krieger. (2010). Shear stress induces nitric oxide-mediated vascular endothelial growth factor production in human adipose tissue mesenchymal stem cells. Stem Cells Dev 19:371-378
119. Cao Y, Z Sun, L Liao, Y Meng, Q Han and RC Zhao. (2005). Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 332:370-379
120. Lee EJ, HW Park, HJ Jeon, HS Kim and MS Chang. (2013). Potentiated therapeutic angiogenesis by primed human mesenchymal stem cells in a mouse model of hindlimb ischemia. Regen Med 8:283-293
121. Huang WH, HL Chen, PH Huang, TL Yew, MW Lin, SJ Lin and SC Hung. (2014). Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients. Cardiovasc Res 101:266-276
122. Mikami S, A Nakashima, K Nakagawa, T Maruhashi, Y Iwamoto, M Kajikawa, T Matsumoto, Y Kihara, K Chavama, et al. (2013). Autologous bone-marrow mesenchymal stem cell implantation and endothelial function in a rabbit ischemic limb model. PLoS One 8:e67739
123. Zhao Y, S Zhang, J Zhou, J Wang, M Zhen, Y Liu, J Chen and Z Qi. (2010). The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cells. Biomaterials 31:296-307
124. Hashi CK, Y Zhu, GY Yang, WL Young, BS Hsiao, K Wang, Chu B and S Li. (2007). Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A 104: 11915-11920
125. Hjortnaes J, D Gottlieb, JL Figueiredo, J Melero-Martin, RH Kohler, J Bischoff, R Weissleder, JE Mayer and E Aikawa. (2010). Intravital molecular imaging of smalldiameter tissue-engineered vascular grafts in mice: a feasibility study. Tissue Eng Part C Methods 16:597-607
126. Wexler SA, C Donaldson, P Denning-Kendall, C Rice, B Bradley and JM Hows. (2013). Adult bone marrow is a rich source of human mesenchymal stem cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121:368-374
127. Baer PC and H Geiger. (2012). Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int 2012:812693
128. Wang S, X Qu and R Zhao. (2012). Clinical applications of mesenchymal stem cells. J Hematol Oncol 5:19
129. Trounson A, RG Thakar, G Lomax and D Gibbons. (2011). Clinical trials for stem cell therapies. BMC Med 9:52
130. Menendez-Menendez Y, M Alvarez-Viejo, A Ferrero-Gutierrez, M Perez-Basterrechea and S Perez. (2014). Adult stem cell therapy in chronic wound healing. J Stem Cell Res Ther 4:162
131. Hibino N, E McGillicuddy, G Matsumura, Y Ichihara, Y Naito, C Breuer and T Shinoka. (2010). Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 139:431-436
132. Lindroos B, R Suuronen and S Miettinen. (2011). The potential of adipose stem cells in regenerative medicine. Stem Cell Rev 7:269-291
133. Unger C, H Skottman, P Blomberg, MS Dilber and O Hovatta. (2008). Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 17:R48-R53
134. Lanzendorf SE, CA Boyd, DL Wright, S Muasher, S Oehninger and GD Hodgen. (2001). Use of human gametes obtained from anonymous donors for the production of human embryonic stem cell lines. Fertil Steril 76:132-137
135. Richards M, CY Fong, WK Chan, PC Wong and A Bongso. (2002). Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 20:933-936
136. Hovatta O, M Mikkola, K Gertow, AM Strömberg, J Inzunza, J Hreinsson, B Rozell, E Blennow, M Andäng and L Ahrlund-Richter. (2003). A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod 18:1404-1409
137. Mitalipova M, J Calhoun, S Shin, D Wininger, T Schulz, S Noggle, A Venable, I Lyons, A Robins and S Stice. (2003). Human embryonic stem cell lines derived from discarded embryos. Stem Cells 21:521-526
138. Heins N, MC Englund, C Sjöblom, U Dahl, A Tonning, C Bergh, A Lindahl, C Hanson and H Semb. (2004). Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells 22:367-376
139. Lee JB, JE Lee, JH Park, SJ Kim, MK Kim, SI Roh and HS Yoon. (2005). Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition. Biol Reprod 72:42-49
140. Inzunza J, K Gertow, MA Strömberg, E Matilainen, E Blennow, H Skottman, S Wolbank, L Ahrlund-Richter and O Hovatta. (2005). Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 23:544-549
141. Hong-mei P and C Gui-An. (2006). Serum-free medium cultivation to improve efficacy in establishment of human embryonic stem cell lines. Hum Reprod 21:217-222
142. Genbacev O, A Krtolica, T Zdravkovic, E Brunette, S Powell, A Nath, E Caceres, M McMaster, S McDonagh, et al. (2005). Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. Fertil Steril 83:1517-1529
143. Wang Q, ZF Fang, F Jin, Y Lu, H Gai and HZ Sheng. (2005). Derivation and growing human embryonic stem cells on feeders derived from themselves. Stem Cells 23:1221-1227
144. Fatimah SS, GC Tan, K Chua, MM Fariha, AE Tan and AR Hayati. (2013). Stemness and angiogenic gene expression changes of serial-passage human amnion mesenchymal cells. Microvasc Res 86:21-29
145. Rossi D, S Pianta, M Magatti, P Sedlmayr and O Parolini. (2012). Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity. PLoS One 7: e46956
146. Wolbank S, A Peterbauer, M Fahrner, S Hennerbichler, M van Griensven, G Stadler, H Redl and C Gabriel. (2007). Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13:1173-1183
147. Zhao P, H Ise, M Hongo, M Ota, I Konishi and T Nikaido. (2005). Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 79: 528-535
148. Vellasamy S, P Sandrasaigaran, S Vidyadaran, E George and R Ramasamy. (2012). Isolation and characterization of mesenchymal stem cells derived from human placenta tissue. World J Stem Cells 4:53-61
149. Rus Ciuca D, O Sorit xau, S Susxman, VI Pop and CM Mihu. (2011). Isolation and characterization of chorionic mesenchyal stem cells from the placenta. Rom J Morphol Embryol 52:803-808
150. Zhang X, A Mitsuru, K Igura, K Takahashi, S Ichinose, S Yamaguchi and TA Takahashi. (2006). Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Biochem Biophys Res Commun 340:944-952
151. Pasquinelli G, P Tazzari, F Ricci, C Vaselli, M Buzzi, R Conte, C Orrico, L Foroni, A Stella, et al. (2007). Ultrastructural characteristics of human mesenchymal stromal (stem) cells derived from bone marrow and term placenta. Ultrastruct Pathol 31:23-31
152. Soncini M, E Vertua, L Gibelli, F Zorzi, M Denegri, A Albertini, GS Wengler and O Parolini. (2007). Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 1:296-305
153. Portmann-Lanz CB, A Schoeberlein, A Huber, R Sager, A Malek, W Holzgreve and DV Surbek. (2006). Placental mesenchymal stem cells as potential autologous graft for pre-And perinatal neuroregeneration. Am J Obstet Gynecol 194:664-673
154. Battula VL, PM Bareiss, S Treml, S Conrad, I Albert, S Hojak, H Abele, B Schewe, L Just, T Skutella and HJ Bühring. (2007). Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differ Res Biol Divers 75:279-291
155. Divya MS, GE Roshin, TS Divya, VA Rasheed, TR Santhoshkumar, KE Elizabeth, J James and RM Pillai. (2012). Umbilical cord blood-derived mesenchymal stem cells consist of a unique population of progenitors coexpressing mesenchymal stem cell and neuronal markers capable of instantaneous neuronal differentiation. Stem Cell Res Ther 3:57
156. Lindner U, J Kramer, J Rohwedel and P Schlenke. (2010). Mesenchymal stem or stromal cells: toward a better understanding of their biology? Transfus Med Hemother 37:75-83
157. Zhang X, M Hirai, S Cantero, R Ciubotariu, L Dobrila, A Hirsh, K Igura, H Satoh, I Yokomi, et al. (2011). Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem 112:1206-1218
158. Schneider RK, A Püllen, R Kramann, J Bornemann, R Knüchel, S Neuss and A Perez-Bouza. (2010). Long-term survival and characterisation of human umbilical cordderived mesenchymal stem cells on dermal equivalents. Differ Res Biol Divers 79:182-193
159. De Bruyn C, M Najar, G Raicevic, N Meuleman, K Pieters, B Stamatopoulos, A Delforge, D Bron and L Lagneaux. (2011). A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Whartons jelly without enzymatic treatment. Stem Cells Dev 20:547-557
160. La Rocca G, R Anzalone, S Corrao, F Magno, T Loria, M Lo Iacono, A Di Stefano, P Giannuzzi, L Marasa, et al. (2009). Isolation and characterization of Oct-4 + /HLAG+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 131:267-282
161. LLu LL, YJ Liu, SG Yang, QJ Zhao, X Wang, W Gong, ZB Han, ZS Xu, YX Lu, et al. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91:1017-1026
162. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147
163. Zhu X, W Shi, W Tai and F Liu. (2012). The comparition of biological characteristics and multilineage differentiation of bone marrow and adipose derived Mesenchymal stem cells. Cell Tissue Res 350:277-287
164. Peter S, AM Scutt, PC Wright and CA Biggs. (2013). Comparative study of in vitro expansion of bone marrowderived mesenchymal stem cells. Biotechnol Lett 35:463-469
165. Peptanariu D, M Zlei, A Negura and E Carasevici. (2012). Optimization of culture conditions for bone marrow stromal cells in RPMI-1640 medium. Rev Med Chir Soc Med Nat Iasi 116:222-227
166. Noort WA, MI Oerlemans, H Rozemuller, D Feyen, S Jaksani, D Stecher, B Naaijkens, AC Martens, HJ Bühring, PA Doevendans and JP Sluijter. (2012). Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med 16:1827-1839
167. Boxall SA and E Jones. (2012). Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 10:1155
168. Lee MW, DS Kim, KH Yoo, HR Kim, IK Jang, JH Lee, SY Kim, MH Son, et al. (2013). Human bone marrowderived mesenchymal stem cell gene expression patterns vary with culture conditions. Blood Res 48:107-114
169. Pierantozzi E, B Gava, I Manini, F Roviello, G Marotta, M Chiavarelli and V Sorrentino. (2011). Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2. Stem Cells Dev 20:915-923
170. Martínez-Lorenzo MJ, M Royo-Canas, E Alegre-Aguarón, P Desportes, T Castiella, F García-Alvarez and L Larrad. (2009). Phenotype and chondrogenic differentiation of mesenchymal cells from adipose tissue of different species. J Orthop Res 27:1499-1507
171. González MA, E Gonzalez-Rey, L Rico, D Büscher and M Delgado. (2009). Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136:978-989
172. Sachs PC, MP Francis, M Zhao, J Brumelle, RR Rao, LW Elmore and SE Holt. (2012). Defining essential stem cell characteristics in adipose-derived stromal cells extracted from distinct anatomical sites. Cell Tissue Res 349:505-515
173. Wan Safwani WK, S Makpol, S Sathapan and KH Chua. (2011). The changes of stemness biomarkers expression in human adipose-derived stem cells during long-term manipulation. Biotechnol Appl Biochem 58:261-270
174. Hilkens P, P Gervois, Y Fanton, J Vanormelingen, W Martens, T Struys, C Politis, I Lambrichts and A Bronckaers. (2013). Effect of isolation methodology on stem cell properties and multilineage differentiation potential of human dental pulp stem cells. Cell Tissue Res 353:65-78
175. Ferro F, R Spelat, AP Beltrami, D Cesselli and F Curcio. (2012). Isolation and characterization of human dental pulp derived stem cells by using media containing low human serum percentage as clinical grade substitutes for bovine serum. PLoS One 7:e48945
176. Kerkis I and AI Caplan. (2012). Stem cells in dental pulp of deciduous teeth. Tissue Eng Part B Rev 18:129-138
177. Fournier BP, FC Ferre, L Couty, JJ Lataillade, M Gourven, A Naveau, B Coulomb, A Lafont and B Gogly. (2010). Multipotent progenitor cells in gingival connective tissue. Tissue Eng Part A 16:2891-2899
178. Tang L, N Li, H Xie and Y Jin. (2011). Characterization of mesenchymal stem cells from human normal and hyperplastic gingiva. J Cell Physiol 226:832-842
179. Ge S, KM Mrozik, D Menicanin, S Gronthos and PM Bartold. (2012). Isolation and characterization of mesenchymal stem cell-like cells from healthy and inflamed gingival tissue: potential use for clinical therapy. Regen Med 7:819-832
180. Naveau A, JJ Lataillade, BP Fournier, L Couty, M Prat, FC Ferre, M Gourven, E Durand, B Coulomb, A Lafont and B Gogly. (2011). Phenotypic study of human gingival fibroblasts in a medium enriched with platelet lysate. J Periodontol 82:632-641
181. LeeM-Y, JPHuang, YYChen, JDAplin, YHWu, CYChen, PC Chen and CP Chen. (2009). Angiogenesis in differentiated placental multipotent mesenchymal stromal cells is dependent on integrin alpha5beta1. PLoS One 4:e6913
182. Fariha MN, KH Chua, GC Tan, YH Lim and AR Hayati. (2013). Pro-Angiogenic potential of human chorionderived stem cells: in vitro and in vivo evaluation. J Cell Mol Med 17:681-692
183. Magatti M, S De Munari, E Vertua, L Gibelli, GS Wengler and O Parolini. (2008). Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells 26:182-192
184. Parolini O, F Alviano, I Bergwerf, D Boraschi, C De Bari, P De Waele, M Dominici, M Evangelista, W Falk, et al. (2010). Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells Dev 19:143-154
185. Parolini O and M Caruso. (2011). Review: preclinical studies on placenta-derived cells and amniotic membrane: an update. Placenta 32:S186-S195
186. Cargnoni A, L Gibelli, A Tosini, PB Signoroni, C Nassuato, D Arienti, G Lombardi, A Albertini, GS Wengler and O Parolini. (2009). Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycininduced lung fibrosis. Cell Transplant 18:405-422
187. Teng Z, T Yoshida, M Okabe, A Toda, O Higuchi, M Nogami, N Yoneda, K Zhou, S Kyo, T Kiyono and T Nikaido. (2013). Establishment of immortalized human amniotic mesenchymal stem cells. Cell Transplant 22: 267-278
188. Chou MT, SN Chang, C Ke, HI Chang, ML Sung, HC Kuo and CN Chen. (2010). The proliferation and differentiation of placental-derived multipotent cells into smooth muscle cells on fibrillar collagen. Biomaterials 31:4367-4375
189. Alaminos M, B Pérez-Köhler, I Garzón, N García-Honduvilla, B Romero, A Campos and J Bujan. (2010). Transdifferentiation potentiality of human Whartons jelly stem cells towards vascular endothelial cells. J Cell Physiol 223:640-647
190. Doan CC, TL Le, NS Hoang, NT Doan, VD Le and MS Do. (2014). Differentiation of umbilical cord lining membrane-derived mesenchymal stem cells into endothelial-like cells. Iran Biomed J 18:67-75
191. Bongso A and CY Fong. (2013). The therapeutic potential, challenges and future clinical directions of stem cells from the Whartons jelly of the human umbilical cord. Stem Cell Rev 9:226-240
192. Roh JD, MP Brennan, RI Lopez-Soler, PM Fong, A Goyal, A Dardik and CK Breuer. (2007). Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques. J Pediatr Surg 42:198-202
193. Liu JW, S Dunoyer-Geindre, V Serre-Beinier, G Mai, JF Lambert, RJ Fish, Pernod G, H Bounameaux and EK Kruithof. (2007). Characterization of endothelial-like cells derived from human mesenchymal stem cells. J Thromb Haemost 5:826-834
194. Chen PM, ML Yen, KJ Liu, HK Sytwu and BL Yen. (2011). Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci 18:49
195. Griffin MD, T Ritter and BP Mahon. (2010). Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 21:1641-1655
196. Shen J, Y Huang, S Xu, P Zheng, W Yin, J Cen and LZ Gong. (2012). Effectiveness of human mesenchymal stem cells derived from bone marrow cryopreserved for 23-25 years. Cryobiology 64:167-175
197. Zhuo Y, SH Li, MS Chen, J Wu, HYM Kinkaid, S Fazel, RD Weisel and RK Li. (2010). Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients. J Thorac Cardiovasc Surg 139:1286-1294
198. Romanov YA, VA Svintsitskaya and VN Smirnov. (2003). Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21:105-110
199. Kinner B, JM Zaleskas and M Spector. (2002). Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp Cell Res. 278:72-83
200. Tamama K, CK Sen and A Wells. (2008). Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells Dev 17:897-908
201. Au P, J Tam, D Fukumura and RK Jain. (2008). Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 111: 4551-4558
202. Zhang Y, HK Lin, D Frimberger, RB Epstein and BP Kropp. (2005). Growth of bone marrow stromal cells on small intestinal submucosa: an alternative cell source for tissue engineered bladder. BJU Int 96:1120-1125
203. Zonari A, S Novikoff, NRP Electo, NM Breyner, DA Gomes, A Martins, NM Neves, RL Reis and AM Goes. (2012). Endothelial differentiation of human stem cells seeded onto electrospun polyhydroxybutyrate/ polyhydroxybutyrate-co-hydroxyvalerate fiber mesh. PLoS One 7:e35422
204. Martínez-Estrada OM, Y Munoz-Santos, J Julve, M Reina and S Vilaró. (2005). Human adipose tissue as a source of Flk-1 + cells: new method of differentiation and expansion. Cardiovasc Res 65:328-333
205. Marino G, F Rosso, P Ferdinando, A Grimaldi, G De Biasio, G Cafiero, MBarbarisi and A Barbarisi. (2012). Growth and endothelial differentiation of adipose stem cells on polycaprolactone. J Biomed Mater Res A 100:543-548
206. Scherberich A, R Galli, C Jaquiery, J Farhadi and I Martin. (2007). Three-dimensional perfusion culture of human adipose tissue-derived endothelial and osteoblastic progenitors generates osteogenic constructs with intrinsic vascularization capacity. Stem Cells 25:1823-1829
207. Montespan F, F Deschaseaux, L Sensébé, ED Carosella and N Rouas-Freiss. (2014). Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy. J Immunol Res 2014:230346
208. Pikua M, N Marek-Trzonkowska, A Wardowska, A Renkielska and P Trzonkowski. (2013). Adipose tissuederived stem cells in clinical applications. Expert Opin Biol Ther 13:1357-1370
209. Schipper BM, KG Marra, W Zhang, AD Donnenberg and JP Rubin. (2008). Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann Plast Surg 60:538-544
210. Choudhery MS, M Badowski, A Muise, J Pierce and DT Harris. (2014). Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation. J Transl Med 12:8
211. Rodríguez LV, Z Alfonso, R Zhang, J Leung, B Wu and LI Ignarro. (2006). Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci U S A 103:12167-12172
212. Park IS, SH Kim, DN Heo, Y Jung, IK Kwon, JW Rhie and SH Kim. (2011). Synergistic effect of biochemical factors and strain on the smooth muscle cell differentiation of adipose-derived stem cells on an elastic nanofibrous scaffold. J Biomater Sci Polym Ed 23:1579-1593
213. Wang C, S Yin, L Cen, Q Liu, W Liu, Y Cao and L Cui. (2010). Differentiation of adipose-derived stem cells into contractile smooth muscle cells induced by transforming growth factor-beta1 and bone morphogenetic protein-4. Tissue Eng Part A 16:1201-1213
214. Zhao Z, H Yu, F Xiao, X Wang, S Yang and S Li. (2012). Differentiation of adipose-derived stem cells promotes regeneration of smooth muscle for ureteral tissue engineering. J Surg Res 178:55-62.